Detalles de la búsqueda
1.
Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries.
Leukemia;
36(4): 913-922, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34775483
2.
A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries.
Blood Cancer J;
12(7): 107, 2022 07 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35821023
3.
Venetoclax combination therapy with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukaemia.
Ther Adv Hematol;
12: 20406207211040335, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34471510
Resultados
1 -
3
de 3
1
Próxima >
>>